Skip to main content
. 2016 May 23;6:26544. doi: 10.1038/srep26544

Figure 4. Association of the CYP3A4*1G and CYP3A5*3 single-nucleotide polymorphism with atorvastatin and its metabolites.

Figure 4

(a1,b1) Reduction rate of atorvastatin; (a2,b2) Formation rate of ortho-hydroxy atorvastatin; (a3,b3) Formation rate of para-hydroxy atorvastatin.